Key result
COVID-19 complicated by Takotsubo cardiomyopathy was associated with a 57% in-hospital mortality rate, reaching 100% in patients with high-risk echocardiographic features.
Why the study?
Clinical characteristics and outcomes of patients with COVID-19 complicated by secondary Takotsubo cardiomyopathy were poorly understood.
Observational (n=7)
Yes
COVID-19 complicated by secondary Takotsubo cardiomyopathy is associated with a high in-hospital mortality rate, particularly in patients with high-risk echocardiographic features.
No takes yet. Share an insight, caveat, or question.
High mortality in this case series warrants vigilance; hypothesis-generating for echo-based risk stratification in COVID-19 Takotsubo.
Hegde et al. (2020) conducted an observational in COVID-19 complicated by Takotsubo cardiomyopathy (n=7). Takotsubo cardiomyopathy in COVID-19 was evaluated on In-hospital death. COVID-19 complicated by Takotsubo cardiomyopathy was associated with a 57% in-hospital mortality rate, reaching 100% in patients with high-risk echocardiographic features.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: